253 related articles for article (PubMed ID: 35592841)
21. Incidence of congenital hypothyroidism in China: data from the national newborn screening program, 2013-2015.
Deng K; He C; Zhu J; Liang J; Li X; Xie X; Yu P; Li N; Li Q; Wang Y
J Pediatr Endocrinol Metab; 2018 Jun; 31(6):601-608. PubMed ID: 29715190
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
[TBL] [Abstract][Full Text] [Related]
23. Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model.
Chen K; Zhong Y; Gu Y; Sharma R; Li M; Zhou J; Wu Y; Gao Y; Qin G
JAMA Netw Open; 2020 Dec; 3(12):e2023949. PubMed ID: 33275150
[TBL] [Abstract][Full Text] [Related]
24. Costs and benefits of neurosurgical intervention for infant hydrocephalus in sub-Saharan Africa.
Warf BC; Alkire BC; Bhai S; Hughes C; Schiff SJ; Vincent JR; Meara JG
J Neurosurg Pediatr; 2011 Nov; 8(5):509-21. PubMed ID: 22044378
[TBL] [Abstract][Full Text] [Related]
25. Cost Per DALY Averted in a Surgical Unit of a Private Hospital in India.
Chatterjee S; Laxminarayan R; Gosselin RA
World J Surg; 2016 May; 40(5):1034-40. PubMed ID: 26675929
[TBL] [Abstract][Full Text] [Related]
26. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011.
Mangen MJ; Bouwknegt M; Friesema IH; Haagsma JA; Kortbeek LM; Tariq L; Wilson M; van Pelt W; Havelaar AH
Int J Food Microbiol; 2015 Mar; 196():84-93. PubMed ID: 25528537
[TBL] [Abstract][Full Text] [Related]
27. Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis.
Lim AG; Scott N; Walker JG; Hamid S; Hellard M; Vickerman P
PLoS Med; 2021 Oct; 18(10):e1003818. PubMed ID: 34665815
[TBL] [Abstract][Full Text] [Related]
28. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
[TBL] [Abstract][Full Text] [Related]
29. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
[TBL] [Abstract][Full Text] [Related]
30. Economic Valuation of the Global Burden of Cleft Disease Averted by a Large Cleft Charity.
Poenaru D; Lin D; Corlew S
World J Surg; 2016 May; 40(5):1053-9. PubMed ID: 26669788
[TBL] [Abstract][Full Text] [Related]
31. Cost Effectiveness of Implementing Integrated Management of Neonatal and Childhood Illnesses Program in District Faridabad, India.
Prinja S; Bahuguna P; Mohan P; Mazumder S; Taneja S; Bhandari N; van den Hombergh H; Kumar R
PLoS One; 2016; 11(1):e0145043. PubMed ID: 26727369
[TBL] [Abstract][Full Text] [Related]
32. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
Kuznik A; Habib AG; Munube D; Lamorde M
BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
[TBL] [Abstract][Full Text] [Related]
33. Estimating a cost-effectiveness threshold for health care decision-making in South Africa.
Edoka IP; Stacey NK
Health Policy Plan; 2020 Jun; 35(5):546-555. PubMed ID: 32125375
[TBL] [Abstract][Full Text] [Related]
34. Etiological Profile, Targeted Levothyroxine Dosing and Impact of Partial Newborn Screening in Congenital Hypothyroidism-A Single Centre Experience.
Nagendra L; Bhavani N; Pavithran PV; Shenoy M; Menon UV; Abraham N; Nair V; Kumar H
Indian J Endocrinol Metab; 2023; 27(5):445-449. PubMed ID: 38107726
[TBL] [Abstract][Full Text] [Related]
35. Health and economic benefits of public financing of epilepsy treatment in India: An agent-based simulation model.
Megiddo I; Colson A; Chisholm D; Dua T; Nandi A; Laxminarayan R
Epilepsia; 2016 Mar; 57(3):464-74. PubMed ID: 26765291
[TBL] [Abstract][Full Text] [Related]
36. Cancers: What Are the Costs in Relation to Disability-Adjusted Life Years? A Systematic Review and Meta-Analysis.
Garlasco J; Nurchis MC; Bordino V; Sapienza M; Altamura G; Damiani G; Gianino MM
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457733
[TBL] [Abstract][Full Text] [Related]
37. The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study.
Wanjau MN; Kivuti-Bitok LW; Aminde LN; Veerman JL
Cost Eff Resour Alloc; 2023 Sep; 21(1):69. PubMed ID: 37735408
[TBL] [Abstract][Full Text] [Related]
38. Estimation of the health and economic burden of neurocysticercosis in India.
Singh BB; Khatkar MS; Gill JP; Dhand NK
Acta Trop; 2017 Jan; 165():161-169. PubMed ID: 26802489
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
